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Abstract
Renal cell carcinoma is the most common form of malignant renal tumour and is extremely lethal.
About 25% of the patients develop metastasis at the time of diagnosis, and in many cases during the
course of the disease, affecting the lung, lymphatic ganglions, liver, and bone, with skin metastases
being quite rare.
A 73-year-old patient, who had undergone surgery for adenocarcinoma in the left kidney 10 years
previously, visited the dermatological service due to the appearance of recent, rapidly-developing
lesion at the back of his neck. It was decided to remove it surgically. The histological study confirmed
clear cell carcinoma that was probably of renal origin. A computed tomography scan was performed
on the thorax and abdomen, and lesions were observed that were compatible with metastasis in the
right kidney and left lung. Treatment with a multikinase angiogenesis inhibitor (sunitib) was started.
Due to the late development of the skin metastases and those in other regions that worsen the
prognosis, these patients must be subjected to long-term clinical observation. Urologist should pay
attention to cutaneous lesion appearing in these patients as in many times they look like benign lesion.
Introduction
Renal Cell Carcinoma (RCC) currently accounts for 90%
of all renal tumours, and is the most lethal of urological
tumours. Its frequency has increased by 2.5% per annum.
Thanks to the increase in image diagnosis (ultrasound, CT
scan, MRI) in recent years, these tumours are easier to
diagnose at an early stage of the disease. However, it
continues to be a highly lethal tumour in the event of the
disease being widely disseminated at the time of diagnosis.
Approximately 25% of patients diagnosed for RCC are
shown to have metastasis at the time of the diagnosis, and
these are more frequent in the following order: lungs,
lymphatic ganglions, bone, liver, contralateral kidney,
adrenal and ipsilateral glands, brain and other less
frequent locations such as the skin [1,2].
A case study is presented consisting of a male patient aged
73 years who had undergone a left radical nephrectomy
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10 years ago for grade 3 Fuhrman’s renal adenocarcinoma.
Skin lesion had developed 2 months ago on the patient’s
neck, and a histological diagnosis confirmed the presence
of clear cells, showing positive for EMA, CEA andCD10 [3].
Case presentation
Caucasian and Spanish patient aged 73 years with minor
renal failure on whom a left radical nefrectomy for renal
adenocarcinoma had been performed 10 years ago in the
Urology Unit. The patient was referred to the Dermatolo-
gical Unit for an asymptomatic lesion at the back of his
neck that had developed 2 months previously. The
examination revealed the presence of a tumour with a
firm consistency, bluish-red in colour, with a somewhat
hyperkeratous surface and maximum diameter of 2.5 cm,
which was initially diagnosed as a possible angioma.
Surgical treatment was indicated due to the late
development of the lesion and its rapid growth. The
histopathological study revealed the presence of groups of
irregular cells with cytological irregularities (large nuclei
andprominent nucleoles) and clear cytoplasm (Figure 1D).
The IHC (immunohistochemistry) (Figure 1C) test showed
positive for CD10, EMA, CEA, vimentin, and pancytoker-
atin and it was therefore diagnosed as a Clear Cell
Carcinoma that was probably of renal origin, taking into
account the patient’s history.
In view of the histological results, it was decided to request
a CT scan of the abdomen and pelvis which showed an
heterogeneous image with a maximum diameter of 3.7 cm
in the middle of the right kidney (Figure 1A), suggesting
metastasis of a renal adenocarcinoma in the kidney that
had been removed and a nodule with a maximum
diameter of 2.5 cm in the lower lobule of the left lung
Figure 1. (A) A 3.7 cm heterogeneous image in the middle of the right kidney. (B) A 2.5 cm nodule in the lower lobule in left
lung. (C) The IHC test showed positive for CD10. (D) Goups of irregular cells with cytological irregularities (large nuclei and
prominent nucleoles) and clear cytoplasm are observed in dermis (Hematoxylin-Eosin).
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that seemed to correspond with another metastasis of the
same adenocarcinoma (Figure 1B). Those findings were
not present in the CT scan of the abdomen and pelvis
performed on the patient 12 months previously.
Due to the presence of multiple metastases, it was decided
to refer the patient to the Cancer Unit for evaluation and
the administration of medication with angiogenesis/
multikinase inhibitors.
Discussion
Owing to the clinical and evolutive particularities of the
RCC, in certain cases diagnosis of this condition is made at
a late stage of the disease when the cancer is widespread
and has metastasised in different areas of the body. The
development of skin metastases accounting for between
1 and 3% of all metastases. Themost usual location of skin
metastases in these patients is the scalp and face, and they
are usually single lesions that grow rapidly, are bluish-red
in colour and sometimes pulsating [1,4], differential
diagnosis performed macroscopically is necessary to rule
out angioma, cutaneous horns, basal cell carcinoma and
microscopically to rule out xanthoma, xanthelasma,
sebaceous adenoma, sebaceous carcinoma, sebaceous
epithelioma, balloon cell nevi, clear cell hydro adenomas
and other skin pathologies characterised by the presence of
clear cells [3,5]. The performing of IHC techniques
currently makes it possible to conduct differential diag-
nosis of those lesions. EMA, CEA, CD-10 and recently,
RCC-MA (positive in 60% of all RCC skin lesions) are all
markers that suggest skin metastases of renal origin [3,5].
Inmost of the cases published regarding patients with RCC,
the development of skin metastases takes place within six
months to five years of the initial diagnosis and after
performing the nefrectomy [1,2,6], except in some cases in
which RCC has been diagnosed after removing the skin
lesion [3,4]. Inour case, thedevelopment of skinmetastases
occurred ten years after the nefrectomy, which is not
common during the natural course of the disease. We
should highlight the importance of a precise histological
diagnosis to permit the correct identification of the skin
lesion in order to complete an extension study, since in up
to 75% of cases, concomitant organic metastases develop.
In this way, it was possible to diagnose other metastatic
lesions in the lung and contralateral kidney that had not
been detected during routine patient monitoring [7,3].
Treatment ofmetastatic renal adenocarcinoma consists of a
combination of surgical treatment (radical nephrectomy)
and angiogenesis/multikinase inhibitors (sunitinib or
sorafenib). However, treatment of single skin lesions is
usually surgical [3], except in certain cases in which
radiotherapy is an option [8,9]. In this case, due to the
late development of multiple metastases following the
nefrectomy, it was decided to operate on the patient and
remove the skin lesions followed by treatment with
multikinase inhibitors that have shown a significant
increase in the possibilities of survival compared to other
medical therapies (Interferon or Interleukins) in treating
renal cell carcinoma [4].
In short, we wish to emphasise the peculiar natural history
of renal adenocarcinoma, in addition to the need for
exhaustivemonitoring of these patients evenup to ten years
after the initial diagnosis, due to the development of late
metastases that worsen the clinical prognosis and reduce
life expectancy, showing an average survival rate after
diagnosingmetastasis, of between 7 and 32months [2,10].
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